Graphene Oxide Grafted Silica Gel Cochlear Implant Electrode
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Medical silica gel implants face issues with poor hydrophilicity, bacterial adhesion, and cytotoxicity, leading to complications such as deformation, displacement, and infection due to its hydrophobic nature and the cytotoxic effects of commonly used antibacterial agents.
Innovation Solution
A graphene oxide cochlear implant electrode is developed, where silica gel is grafted with graphene oxide to enhance hydrophilicity and antibacterial properties, reducing cytotoxicity, and featuring a specific design with platinum-iridium alloy components and a manufacturing method that includes ultraviolet activation and silane coupling for grafting graphene oxide onto the silica gel.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If medical silica gel is used as implant material, then good physical and chemical stability is achieved, but poor hydrophilicity causes tissue envelope formation and displacement
Solution Approach 1:
The patent applies composite materials by combining medical silica gel with hydrophilic substances (such as hydroxyapatite, collagen, or polyethylene glycol) to create a composite implant material. This composite structure maintains the physical and chemical stability of silica gel while introducing hydrophilic properties through the added substances, thereby preventing tissue envelope formation and displacement without sacrificing structural reliability.
Solution Approach 2:
The patent employs parameter changes by modifying the surface properties of medical silica gel through chemical treatment or coating processes. By changing the surface energy parameters and hydrophilicity characteristics of the silica gel, the implant achieves better affinity with body tissues, preventing the formation of contractile tissue envelopes while maintaining the bulk material's stability.
2Object-affected harmful factors
If antibacterial agents are grafted to silica gel surface, then bacterial adhesion is prevented, but cytotoxicity is introduced
Solution Approach 1:
The patent extracts or removes traditional antibacterial agents (such as metallic silver ions) that cause cytotoxicity and replaces them with alternative approaches. By taking out the harmful antibacterial components and using physical surface modifications or biocompatible hydrophilic coatings instead, the implant achieves bacterial resistance without introducing cytotoxic effects.
Solution Approach 2:
The patent employs biocompatible, non-toxic substances that provide temporary antibacterial protection through physical mechanisms rather than chemical toxicity. These materials may offer short-term antibacterial effects through surface properties that prevent bacterial adhesion, without the persistent cytotoxicity of traditional antibacterial agents, allowing safe integration with living tissue.
3Object-affected harmful factors
If silica gel surface is made more hydrophilic, then affinity with body is improved, but manufacturing complexity increases
Solution Approach 1:
The patent applies preliminary action by pre-coating or pre-modifying the silica gel surface with hydrophilic substances before final implant assembly. By performing the hydrophilic modification in advance during the manufacturing process, the complex chemical treatments are completed beforehand, allowing the final implant assembly to be simpler while still achieving the desired hydrophilic surface properties.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The graphene oxide modification improves the silica gel's hydrophilicity and antibacterial properties, reducing bacterial adhesion and cytotoxicity, ensuring safer and more reliable long-term functionality of the cochlear implant electrode by enhancing its affinity with the body and reducing infection risks.
Implementation Method 1
silica gel is grafted with graphene oxide
Implementation Method 2
surface-grafted modification
Implementation Method 3
ultraviolet activation and silane coupling for grafting graphene oxide onto the silica gel
Data Source
AI summary
Disclosed are a graphene oxide cochlear implant electrode and a manufacturing method thereof. The graphene oxide cochlear implant electrode includes an electrode tip, an electrode carrier, electrode contacts, a first positioning ring, a second positioning ring, a boosting portion, an electrode wire, a loop electrode, a loop electrode wire and a wire array, herein the electrode tip is arranged at a foremost portion of the cochlear implant electrode, the electrode carrier is silica gel grafted with a graphene oxide, the electrode carrier wraps the electrode wire and semi-wraps the electrode contacts connected to the electrode wire one by one, and the electrode carrier is slightly curved as a whole; and the electrode wire is connected to the electrode contacts one by one and forms a spiral shape through the first positioning ring, the second positioning ring and the boosting portion. Methyl vinyl silica gel is adopted, and after activation treatment, the graphene oxide is grafted to the silica gel through a silane coupling agent trimethoxysilane, as to form a hydrophilic antibacterial polymer, not only the hydrophilicity of the silica gel is improved, but also the silica gel is endowed with an antibacterial property, and the cytotoxicity thereof is reduced at the same time.